The dogma that hematopoietic SCs can differentiate only into hematopoietic lineage cells has been challenged in the last 10 years by investigators detecting donor-type epithelial cells (ECs) in the lungs, skin, intestine, liver and buccal and nasal mucosa of allogeneic hematopoietic cell transplantation (HCT) recipients. [1] [2] [3] [4] [5] The postulated mechanisms are hematopoietic to epithelial cell transdifferentiation, transdetermination, dedifferentiation, hematopoieticepithelial cell fusion or phagocytosis of donor leukocyte DNA by recipient ECs. However, the following simpler explanation has been discussed, but not reported in the literature: transfer of epithelial cells or their precursors with the hematopoietic cell graft. 6 To assess this possibility, we studied filgrastim-mobilized human PBSC grafts from 10 randomly selected donors, and PBCs from five healthy volunteers (not treated with filgrastim) for the presence of epithelial cells/precursors. The study was approved by the Ethics Committee of the University of Calgary and all subjects signed a written consent. Five million cells from each graft or blood specimen were suspended in 1% PBS and incubated with CD36 (an adhesion molecule expressed on epithelial cells, but also some hematopoietic cells like monocytes or platelets) microbeads (Miltenyi Biotec, Auburn, CA, USA). The CD36 pos cells were magnetically separated using MACS (Miltenyi Biotec), and subsequently fixed, permeabilized and stained with FITC-conjugated cytokeratin (CK) MoAb (Clone CK3-6H5, Miltenyi Biotec), cytospan, stained with 4 0 ,6-diamidino-2-phenylindole (DAPI) nuclear stain, and analyzed by fluorescent microscopy. CK pos cells morphologically resembled epithelial cells (thus we called them epithelial cells) (Figure 1 ). The human Caco-2 epithelial cell line was used as a positive control, and an isotype mouse IgG1 Ab as a negative control.
These CK pos cells that morphologically resembled epithelial cells were detected in all 10 graft specimens and 3/5 peripheral blood specimens. The median count was 15 epithelial cells per five million graft cells (range, 8-34) and five epithelial cells per five million blood mononuclear cells (range, 0-7). The difference between grafts and blood was significant (P ¼ 0.007, Mann-Whitney-Wilcoxon test), suggesting that filgrastim may mobilize epithelial cells. 7 Comparison of circulating epithelial cells in the same individual, before and after filgrastim treatment was not carried out but could be more conclusive. It is important to note that, consistent with our observation, zero or nearzero circulating epithelial cells have been reported in healthy individuals. 8, 9 It is unlikely that the CK pos cells observed by us were skin keratinocyte contaminants, as all the grafts were collected via a central vein apheresis catheter and at the time of the insertion of the catheter into the central vein, 5-8 mL of blood was aspirated and discarded.
We therefore speculate that epithelial cells (or their precursors?) circulate in blood, analogous to precursors of other cells like mesenchymal stromal cells, endothelial cells, osteoblasts or smooth-muscle cells. [10] [11] [12] We also hypothesize that the circulating and harvested epithelial cells/ precursors give rise to the donor-type epithelial cells observed in allo-HCT recipients. This could be further evaluated by assessing whether there is a correlation between the number of epithelial cells/precursors in the graft and the percentage of donor-type epithelial cells in epithelial tissues of the recipient. A limitation of our study is that we identified epithelial cells by phenotype, not by their clonogenic potential. Further studies are needed to evaluate this aspect. In summary, we speculate that incorporation of epithelial cells (or their precursors?) transferred with the graft into recipient epithelium may represent yet another explanation of why donor-type epithelial cells are found in epithelia of HCT recipients.
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